$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.51 | 1,783 | 24,080 | 50,000 | 51.8 K to 50 K (-3.44 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 51,783 | 50 K to 51.8 K (+3.57 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.21 | 3,276 | 46,568 | 50,000 | 53.3 K to 50 K (-6.15 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,276 | 1,966 | 53,276 | 50 K to 53.3 K (+6.55 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 2,500 | 15,000 | 87,632 | |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 2,500 | 1,500 | 0 | |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,784 | 22,704 | 90,132 | |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 5,105 | 30,630 | 33,095 | |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 13.61 | 5,000 | 68,056 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 2,500 | 15,000 | 58,594 | 56.1 K to 58.6 K (+4.46 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 2,500 | 1,500 | 56,094 | 53.6 K to 56.1 K (+4.66 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.04 | 1,633 | 22,925 | 53,594 | 55.2 K to 53.6 K (-2.96 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,633 | 9,798 | 55,227 | 53.6 K to 55.2 K (+3.05 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 485 | 6,790 | 53,594 | 54.1 K to 53.6 K (-0.90 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 485 | 2,910 | 54,079 | 53.6 K to 54.1 K (+0.90 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.05 | 1,992 | 27,982 | 53,594 | 55.6 K to 53.6 K (-3.58 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,992 | 11,952 | 55,586 | 53.6 K to 55.6 K (+3.72 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.08 | 2,103 | 29,604 | 53,594 | 55.7 K to 53.6 K (-3.78 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 2,103 | 12,618 | 55,697 | 53.6 K to 55.7 K (+3.92 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.11 | 1,735 | 24,472 | 53,594 | 55.3 K to 53.6 K (-3.14 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,735 | 10,410 | 55,329 | 53.6 K to 55.3 K (+3.24 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.01 | 941 | 13,179 | 53,594 | 54.5 K to 53.6 K (-1.73 %) |
| Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 941 | 5,646 | 54,535 | 53.6 K to 54.5 K (+1.76 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 200 | 1,200 | 93,916 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 700 | 4,200 | 38,200 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,104 | 6,624 | 94,116 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 2,108 | 12,648 | 38,900 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,000 | 6,000 | 95,220 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 3,276 | 19,656 | 41,008 | |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 900 | 12,600 | 53,594 | 54.5 K to 53.6 K (-1.65 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 900 | 5,400 | 54,494 | 53.6 K to 54.5 K (+1.68 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 3,212 | 44,968 | 53,594 | 56.8 K to 53.6 K (-5.65 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 3,212 | 19,272 | 56,806 | 53.6 K to 56.8 K (+5.99 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 4,276 | 59,864 | 53,594 | 57.9 K to 53.6 K (-7.39 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 4,276 | 25,656 | 57,870 | 53.6 K to 57.9 K (+7.98 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 422 | 5,908 | 2,198,773 | 2.2 M to 2.2 M (-0.02 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,980 | 27,720 | 2,199,195 | 2.2 M to 2.2 M (-0.09 %) |
| Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 2,503 | 35,042 | 2,201,175 | 2.2 M to 2.2 M (-0.11 %) |
| Mar 13 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 400 | 240 | 33,333 | |
| Mar 13 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 14.16 | 400 | 5,662 | 50,000 | 50.4 K to 50 K (-0.79 %) |
| Mar 13 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 400 | 240 | 50,400 | 50 K to 50.4 K (+0.80 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,890 | 11,340 | 96,220 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 2,858 | 17,148 | 44,284 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 1,890 | 11,340 | 98,110 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 6.00 | 2,858 | 17,148 | 47,142 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 18,498 | 11,099 | 2,500 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.01 | 1,088 | 15,242 | 53,594 | 54.7 K to 53.6 K (-1.99 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,088 | 6,528 | 54,682 | 53.6 K to 54.7 K (+2.03 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 2,600 | 36,405 | 53,594 | 56.2 K to 53.6 K (-4.63 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 2,600 | 15,600 | 56,194 | 53.6 K to 56.2 K (+4.85 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 1,100 | 15,405 | 53,594 | 54.7 K to 53.6 K (-2.01 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,100 | 6,600 | 54,694 | 53.6 K to 54.7 K (+2.05 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.01 | 1,100 | 15,414 | 53,594 | 54.7 K to 53.6 K (-2.01 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,100 | 6,600 | 54,694 | 53.6 K to 54.7 K (+2.05 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.01 | 1,087 | 15,228 | 53,594 | 54.7 K to 53.6 K (-1.99 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,087 | 6,522 | 54,681 | 53.6 K to 54.7 K (+2.03 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 1,000 | 14,000 | 53,594 | 54.6 K to 53.6 K (-1.83 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 1,000 | 6,000 | 54,594 | 53.6 K to 54.6 K (+1.87 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 4,748 | 66,472 | 53,594 | 58.3 K to 53.6 K (-8.14 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 6.00 | 4,748 | 28,488 | 58,342 | 53.6 K to 58.3 K (+8.86 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 13.83 | 18,498 | 255,761 | 53,594 | 72.1 K to 53.6 K (-25.66 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 18,498 | 11,099 | 72,092 | 53.6 K to 72.1 K (+34.52 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,100 | 15,405 | 2,203,678 | 2.2 M to 2.2 M (-0.05 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,200 | 16,804 | 2,204,778 | 2.2 M to 2.2 M (-0.05 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,573 | 22,025 | 2,205,978 | 2.2 M to 2.2 M (-0.07 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 3,075 | 43,050 | 2,207,551 | 2.2 M to 2.2 M (-0.14 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.98 | 2,095 | 29,284 | 30,000 | 32.1 K to 30 K (-6.53 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.95 | 700 | 9,765 | 32,095 | 32.8 K to 32.1 K (-2.13 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,154 | 16,156 | 2,210,626 | 2.2 M to 2.2 M (-0.05 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.25 | 105 | 1,496 | 2,211,780 | 2.2 M to 2.2 M (0.00 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.03 | 500 | 7,016 | 2,211,885 | 2.2 M to 2.2 M (-0.02 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.03 | 318 | 4,463 | 2,212,385 | 2.2 M to 2.2 M (-0.01 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.05 | 400 | 5,618 | 2,212,703 | 2.2 M to 2.2 M (-0.02 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 3,064 | 42,896 | 2,213,103 | 2.2 M to 2.2 M (-0.14 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 13.87 | 5,000 | 69,327 | 65,000 | 70 K to 65 K (-7.14 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.97 | 4,247 | 59,329 | 32,795 | 37 K to 32.8 K (-11.47 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.97 | 2,950 | 41,209 | 37,042 | 40 K to 37 K (-7.38 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.96 | 5,008 | 69,935 | 39,992 | 45 K to 40 K (-11.13 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 5,200 | 3,120 | 20,998 | |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 1,742 | 1,045 | 26,198 | |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 4,560 | 2,736 | 27,940 | |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 13.93 | 5,200 | 72,458 | 53,594 | 58.8 K to 53.6 K (-8.84 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 5,200 | 3,120 | 58,794 | 53.6 K to 58.8 K (+9.70 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.02 | 300 | 4,207 | 53,594 | 53.9 K to 53.6 K (-0.56 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 300 | 180 | 53,894 | 53.6 K to 53.9 K (+0.56 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.07 | 200 | 2,813 | 53,594 | 53.8 K to 53.6 K (-0.37 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 200 | 120 | 53,794 | 53.6 K to 53.8 K (+0.37 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.05 | 261 | 3,666 | 53,594 | 53.9 K to 53.6 K (-0.48 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 261 | 157 | 53,855 | 53.6 K to 53.9 K (+0.49 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.03 | 321 | 4,503 | 53,594 | 53.9 K to 53.6 K (-0.60 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 321 | 193 | 53,915 | 53.6 K to 53.9 K (+0.60 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.02 | 260 | 3,646 | 53,594 | 53.9 K to 53.6 K (-0.48 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 260 | 156 | 53,854 | 53.6 K to 53.9 K (+0.49 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.03 | 400 | 5,612 | 53,594 | 54 K to 53.6 K (-0.74 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 400 | 240 | 53,994 | 53.6 K to 54 K (+0.75 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 14.00 | 4,560 | 63,840 | 53,594 | 58.2 K to 53.6 K (-7.84 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 4,560 | 2,736 | 58,154 | 53.6 K to 58.2 K (+8.51 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.78 | 5,982 | 82,421 | 2,216,167 | 2.2 M to 2.2 M (-0.27 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.50 | 9,018 | 121,743 | 2,222,149 | 2.2 M to 2.2 M (-0.40 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,000 | 21,500 | 97,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 102,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 4,901 | 21,074 | 102,599 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,599 | 11,176 | 107,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.14 | 5,000 | 65,677 | 45,000 | 50 K to 45 K (-10.00 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 50,000 | 45 K to 50 K (+11.11 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.56 | 99 | 1,243 | 45,000 | 45.1 K to 45 K (-0.22 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.55 | 4,901 | 61,529 | 45,000 | 49.9 K to 45 K (-9.82 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 4,901 | 21,074 | 49,901 | 45 K to 49.9 K (+10.89 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.56 | 2,599 | 32,650 | 45,000 | 47.6 K to 45 K (-5.46 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,599 | 11,176 | 47,599 | 45 K to 47.6 K (+5.78 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 5,000 | 3,000 | 32,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 5,000 | 3,000 | 37,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 5,000 | 3,000 | 42,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.08 | 5,000 | 60,396 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 5,000 | 3,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.06 | 5,000 | 60,300 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 5,000 | 3,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.08 | 5,000 | 60,408 | 53,594 | 58.6 K to 53.6 K (-8.53 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 5,000 | 3,000 | 58,594 | 53.6 K to 58.6 K (+9.33 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.21 | 6,250 | 82,580 | 50,000 | 56.3 K to 50 K (-11.11 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.22 | 6,250 | 82,621 | 56,250 | 62.5 K to 56.3 K (-10.00 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.23 | 6,250 | 82,699 | 62,500 | 68.8 K to 62.5 K (-9.09 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.22 | 6,250 | 82,609 | 68,750 | 75 K to 68.8 K (-8.33 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 225 | 450 | 157,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 441 | 882 | 157,725 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.91 | 225 | 2,680 | 0 | 225 to 0 (-100.00 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 225 | 450 | 225 | 0 to 225 |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.91 | 441 | 5,254 | 0 | 441 to 0 (-100.00 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 441 | 882 | 441 | 0 to 441 |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.06 | 7,500 | 90,474 | 2,231,167 | 2.2 M to 2.2 M (-0.34 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 2,778 | 5,556 | 158,166 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 2,709 | 5,418 | 160,944 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 3,201 | 6,402 | 163,653 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 2,921 | 5,842 | 166,854 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 3,796 | 7,592 | 169,775 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 3,929 | 7,858 | 173,571 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.89 | 2,778 | 33,033 | 0 | 2.8 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 2,778 | 5,556 | 2,778 | 0 to 2.8 K |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.89 | 2,709 | 32,215 | 0 | 2.7 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 2,709 | 5,418 | 2,709 | 0 to 2.7 K |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.92 | 3,201 | 38,163 | 0 | 3.2 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 3,201 | 6,402 | 3,201 | 0 to 3.2 K |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.92 | 2,921 | 34,825 | 0 | 2.9 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 2,921 | 5,842 | 2,921 | 0 to 2.9 K |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.92 | 3,796 | 45,246 | 0 | 3.8 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 3,796 | 7,592 | 3,796 | 0 to 3.8 K |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.92 | 3,929 | 46,829 | 0 | 3.9 K to 0 (-100.00 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 3,929 | 7,858 | 3,929 | 0 to 3.9 K |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,401 | 10,324 | 110,099 |